The cannabis industry is the fast growing and most rapidly changing industry in the world. The high growth nature of the cannabis industry offers investors a lot of opportunities, however, many of such opportunities are not sound.
The last week has been huge for the global cannabis industry and the market is already seeing positive developments after Canada announced plans to legalize recreational cannabis by July 1, 2018.
Yesterday, one of the world’s largest exchange-traded-fund (ETF) companies announces plans to list the first North American focused cannabis ETF on the Toronto Stock Exchange.
Horizons ETFs Management Canada filed its final prospectus to launch the Horizons Medical Marijuana Life Sciences ETF and the TSX approved the units to be listed and traded on April 5th under the ticker symbol HMMJ.
HMMJ will be the first ETF to offer direct exposure to North American-listed stocks levered to the medical cannabis bioengineering and production. HMMJ is an index (or passively managed) ETF, designed to provide exposure to a basket of North American publicly traded companies with significant business activities in the cannabis industry.
The index is designed to be a liquid and investable index of equity securities of publicly listed life sciences companies, and other firms, with business activities in the marijuana industry.
The index selects from a current universe of publicly-listed North American companies that have operations that may include one or more of biopharmaceuticals, medical manufacturing, distribution, bio-products and other ancillary businesses to the cannabis industry.
The index will only include stocks that meet minimum asset and liquidity thresholds. The index is rebalanced quarterly on a market-capitalization basis, and capped so that no single stock can exceed 10% of the portfolio’s weight when rebalanced.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
